Ziconotide is the first FDA-approved agent in a promising class of drugs called the conotoxins. Its release carried the specific indication for intrathecal use in chronic pain patients.
Spinal epidural steroid injections are commonly utilized in the treatment of acute spinal pain and may provide diagnostic confirmation of a specific "pain generator."